Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Evolution of Nephrology Nursing as Reflected in the Early Nursing Literature.

Robbins KC.

Nephrol Nurs J. 2019 Mar-Apr;46(2):145-154. Review.

PMID:
31009188
2.

The Independent Living Donor Advocate: An Essential Role for Living Kidney Donation.

Robbins KC.

Nephrol Nurs J. 2014 Nov-Dec;41(6):569-73, 586; quiz 574.

PMID:
26287054
3.

Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.

Chaves SS, Daniels D, Cooper BW, Malo-Schlegel S, Macarthur S, Robbins KC, Kobetitsch JF, McDaniel A, D'Avella JF, Alter MJ.

Vaccine. 2011 Dec 6;29(52):9618-23. doi: 10.1016/j.vaccine.2011.10.057. Epub 2011 Oct 30.

PMID:
22044739
4.

Successful use of sodium ferric gluconate in sucrose in a patient with multiple drug allergies.

Robbins KC, Orfitelli C.

Nephrol Nurs J. 2000 Oct;27(5):521-3.

PMID:
16649328
5.

ANNA special interest groups--fast track groups that get the work done!

Robbins KC.

Nephrol Nurs J. 2004 Mar-Apr;31(2):231-3.

PMID:
15114809
6.

Advanced practice in nursing: ethical and role issues in end-of-life care.

Robbins KC.

Nephrol Nurs J. 2004 Jan-Feb;31(1):87-8. No abstract available.

PMID:
15008080
7.

Addressing patient concerns about intravenous iron therapy.

Robbins KC.

Nephrol Nurs J. 2003 Apr;30(2):220-4, 258.

PMID:
12737000
8.

Iron overload in the erythropoietin era.

Robbins KC.

Nephrol Nurs J. 2000 Apr;27(2):227-31. Review.

PMID:
11111550
9.

CHESS: the Comprehensive Health Enhancement Support System. A computer based program for patients and families.

Robbins KC.

Conn Nurs News. 1999 Mar-May;72(1):14. No abstract available.

PMID:
10614238
10.

The future of nephrology nursing: 2000 and beyond.

Robbins KC.

Nephrol News Issues. 1999 Apr;13(4):14-5, 64, 66.

PMID:
10418441
11.
12.

Telenursing: using technology to deliver health care.

Robbins KC.

ANNA J. 1998 Apr;25(2):134. No abstract available.

PMID:
9801495
13.

p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo.

Cardinali M, Jakus J, Shah S, Ensley JF, Robbins KC, Yeudall WA.

Oral Oncol. 1998 May;34(3):211-8.

PMID:
9692056
14.

What is your role? You can make a difference!

Robbins KC.

ANNA J. 1998 Feb;25(1):9, 76. No abstract available.

PMID:
9543902
15.

Nurses do make a difference: but we need to document it!

Robbins KC.

ANNA J. 1997 Oct;24(5):504, 538. No abstract available.

PMID:
9392731
16.

Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck.

Patel V, Jakus J, Harris CM, Ensley JF, Robbins KC, Yeudall WA.

Int J Cancer. 1997 Nov 14;73(4):551-5.

17.

Back to the future in nursing?

Robbins KC.

ANNA J. 1997 Jun;24(3):310, 319. No abstract available.

PMID:
9238902
18.

Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway.

Teramoto H, Salem P, Robbins KC, Bustelo XR, Gutkind JS.

J Biol Chem. 1997 Apr 18;272(16):10751-5.

19.

Iron management in ESRD and the role of the nephrology nurse.

Robbins KC, Senger JM, Kerhulas S, Fishbane S.

ANNA J. 1997 Apr;24(2):265-72; quiz 273-4. Review.

PMID:
9180431
20.

Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck.

Yeudall WA, Jakus J, Ensley JF, Robbins KC.

Mol Carcinog. 1997 Feb;18(2):89-96.

PMID:
9049184
21.

Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck.

Cardinali M, Kratochvil FJ, Ensley JF, Robbins KC, Yeudall WA.

Mol Carcinog. 1997 Feb;18(2):78-88.

PMID:
9049183
22.

RN-tre specifically binds to the SH3 domain of eps8 with high affinity and confers growth advantage to NIH3T3 upon carboxy-terminal truncation.

Matòsková B, Wong WT, Nomura N, Robbins KC, Di Fiore PP.

Oncogene. 1996 Jun 20;12(12):2679-88.

PMID:
8700527
23.

RN-tre identifies a family of tre-related proteins displaying a novel potential protein binding domain.

Matòsková B, Wong WT, Seki N, Nagase T, Nomura N, Robbins KC, Di Fiore PP.

Oncogene. 1996 Jun 20;12(12):2563-71.

PMID:
8700515
24.

CHESS: comprehensive health enhancement support system for women with breast cancer.

Owens BH, Robbins KC.

Plast Surg Nurs. 1996 Fall;16(3):172-5, 182.

PMID:
9060757
25.
26.

Painful realities.

Robbins KC.

Hosp Health Netw. 1995 Nov 20;69(22):62. No abstract available.

PMID:
8528323
27.

Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains.

Rivero-Lezcano OM, Marcilla A, Sameshima JH, Robbins KC.

Mol Cell Biol. 1995 Oct;15(10):5725-31.

28.

Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene.

Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S.

Oncogene. 1995 Jun 15;10(12):2367-77.

PMID:
7784085
29.

Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fc gamma receptors.

Marcilla A, Rivero-Lezcano OM, Agarwal A, Robbins KC.

J Biol Chem. 1995 Apr 21;270(16):9115-20.

30.

Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies.

Cardinali M, Pietraszkiewicz H, Ensley JF, Robbins KC.

Int J Cancer. 1995 Mar 29;61(1):98-103.

PMID:
7705939
31.

MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma.

Yeudall WA, Crawford RY, Ensley JF, Robbins KC.

Carcinogenesis. 1994 Dec;15(12):2683-6.

PMID:
8001221
32.

Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene.

Rivero-Lezcano OM, Sameshima JH, Marcilla A, Robbins KC.

J Biol Chem. 1994 Jul 1;269(26):17363-6.

33.

Nephrology nursing in the future. How will clinical nurses provide care?

Robbins KC.

Nephrol News Issues. 1994 Jun;8(6):44, 48. No abstract available.

PMID:
8008091
34.
35.
36.

Isolation and identification of two proto-oncogene products related to c-fgr and fyn in a tyrosine-protein-kinase fraction of rat spleen.

Brunati AM, James P, Donella-Deana A, Matoskova B, Robbins KC, Pinna LA.

Eur J Biochem. 1993 Aug 15;216(1):323-7.

37.

Involvement of p72syk, a protein-tyrosine kinase, in Fc gamma receptor signaling.

Agarwal A, Salem P, Robbins KC.

J Biol Chem. 1993 Jul 25;268(21):15900-5.

39.
40.
42.

Identification of distinct populations of PI-3 kinase activity following T-cell activation.

Thompson PA, Gutkind JS, Robbins KC, Ledbetter JA, Bolen JB.

Oncogene. 1992 Apr;7(4):719-25.

PMID:
1373484
44.

Diverse biologic properties imparted by the c-fgr proto-oncogene.

Sartor O, Moriuchi R, Sameshima JH, Severino M, Gutkind JS, Robbins KC.

J Biol Chem. 1992 Feb 15;267(5):3460-5.

45.

Dysplasminogenemias.

Robbins KC.

Prog Cardiovasc Dis. 1992 Jan-Feb;34(4):295-308. Review. No abstract available.

PMID:
1530828
46.

Abnormal plasminogen Maywood I.

Robbins KC, Boreisha IG, Godwin JE.

Thromb Haemost. 1991 Nov 1;66(5):575-80.

PMID:
1803622
47.

A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain.

LaRochelle WJ, May-Siroff M, Robbins KC, Aaronson SA.

Genes Dev. 1991 Jul;5(7):1191-9.

48.

Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes.

Gutkind JS, Novotny EA, Brann MR, Robbins KC.

Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4703-7.

49.

Differential association of cellular proteins with family protein-tyrosine kinases.

Sartor O, Sameshima JH, Robbins KC.

J Biol Chem. 1991 Apr 5;266(10):6462-6.

50.

A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes.

Gutkind JS, Link DC, Katamine S, Lacal P, Miki T, Ley TJ, Robbins KC.

Mol Cell Biol. 1991 Mar;11(3):1500-7.

Supplemental Content

Loading ...
Support Center